Tag: Pfizer BioNTech

North Carolina Physicians Demand End to Hospital’s COVID-19 Vaccine Trial on Children

A group of North Carolina physicians is calling for a halt to a hospital system’s COVID-19 vaccine trial on young children. The North Carolina Physicians for Freedom (NCPFF) is demanding that the Atrium Health Levine Children’s Hospital in Charlotte, North Carolina, cease its Pfizer-BioNTech COVID-19 vaccine testing on children aged 6 months to under 5…


Pfizer, BioNTech Ask FDA to Authorize COVID-19 Vaccine Booster for Children Aged 5–11

Pfizer and BioNTech on Tuesday asked the U.S. Food and Drug Administration (FDA) to grant emergency use authorization for a booster for their COVID-19 vaccine for children aged 5- to 11-years-old. Earlier this month, the companies released data from a mid-to-late stage study that they said showed a boost in antibodies from a third dose…


Moderna President: We ‘Strongly Recommend’ 4th Vaccine Dose For Certain Groups

Certain groups of people are likely to benefit from the fourth dose of a COVID-19 vaccine, Moderna President Stephen Hoge said on Monday. The elderly and the immunocompromised are recommended to receive a fourth shot of the vaccine, he said. “For those who are immune-compromised, those who are older adults, over the age of 50…


Call for Investigation Into Increase in Deaths in Young Males in UK

A group of UK doctors, scientists, economists, psychologists, and other academic experts have called for an immediate investigation into the increasing death rate amongst 15- to 19-year-old males. The organisation HART, set up to share concerns about policy and guidance recommendations relating to the COVID-19 pandemic, has written to the British government over a rise…


Pfizer Asks FDA to Authorize COVID-19 Jab for Kids Under 5

Pfizer and its German pharmaceutical partner BioNTech announced they are submitting a request to the U.S. Food and Drug Administration (FDA) to authorize extra-low doses of their COVID-19 vaccine for children 6 months through 4 years of age. The FDA had urged Pfizer-BioNTech to apply for the Emergency Use Authorization (EUA) earlier than the companies had planned….


Australian MP Says Opposition Want Him Silenced for Challenging ‘Pandemic Orthodoxy’

Australian MP George Christensen has hit out at the Labor Party after its deputy opposition leader called for him to be punished for his views on mandatory COVID-19 vaccinations. “Labor are now calling for my removal from parliament for daring to challenge the pandemic orthodoxy,” Christensen wrote on Facebook on Thursday. “Think about it: they…


Judge Gives FDA Just Over 8 Months to Produce Pfizer’s Safety Data

A federal judge on Thursday ordered the U.S. Food and Drug administration to produce the documents it’s relied on to license the Pfizer-BioNTech COVID-19 vaccine, at a rate of 55,000 pages a month. The rate of 55,000 pages a month would mean the FDA has just over eight months to fully produce all of Pfizer’s pre-licensure safety…


Moderna’s COVID-19 Vaccine 4 Times More Likely to Cause Heart Inflammation Than Pfizer’s: Study

A study published in the British Medical Journal late Thursday suggests Moderna’s COVID-19 vaccine is up to four times more likely to cause heart inflammation—myocarditis or myopericarditis—than Pfizer-BioNTech’s COVID-19 vaccine. “Vaccination with [Moderna’s vaccine] was associated with a significantly increased risk of myocarditis or myopericarditis in the Danish population,” and the rate was “threefold to…


Australia Approves Pfizer Vaccine for Kids 5 to 11

Australian health authorities have approved the Pfizer COVID-19 vaccine for all children aged 5 to 11, with the rollout of the vaccine to begin in January. The news of the approval comes after the Therapeutic Goods Administration (TGA) gave the green light to the new formulation of the Pfizer COVID-19 vaccine, also known as Comirnaty, in…


Pfizer Seeks FDA Authorization for COVID-19 Booster Shots in 16-, 17-Year-Olds

Pfizer CEO and Chairman Albert Bourla on Tuesday announced that the company and its partner BioNTech have submitted a request to the U.S. Food and Drug Administration (FDA) seeking to expand authorization for its COVID-19 booster shot for use in 16- and 17-year-olds. It comes after U.S. regulators last week expanded the eligibility for a…